Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R. / Tsongalis, Gregory J.

12 Issues per year


IMPACT FACTOR 2014: 2.707
Rank 6 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2014: 0.741
Source Normalized Impact per Paper (SNIP) 2014: 1.011
Impact per Publication (IPP) 2014: 2.310

VolumeIssuePage

Issues

The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?

1 / Elisa Danese1 / Orazio Ruzzenente1 / Valentina Bresciani2 / Teresita Nuzzo2 / Matteo Gelati1 / Gian Luca Salvagno1 / Massimo Franchi2 / Giuseppe Lippi3 / Gian Cesare Guidi1

1Clinical Biochemistry Laboratory, Department of Life and Reproduction Sciences, University Hospital of Verona, Verona, Italy

2Obstetrics and Gynecology Clinics, Department of Life and Reproduction Sciences, University Hospital of Verona, Verona, Italy

3Clinical Chemistry and Hematology Laboratory, Department of Pathology and Laboratory Medicine, University Hospital of Parma, Parma, Italy

Corresponding author: Dr. Martina Montagnana, Sezione di Biochimica Clinica, Dipartimento di Scienze della Vita e della Riproduzione, Ospedale Policlinico G.B. Rossi, Piazzale Scuro 10, Verona 37134, Italy Phone: +39-045-8126698, Fax: +39-045-8027484

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 49, Issue 3, Pages 521–525, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2011.075, February 2011

Publication History

Received:
2010-08-06
Accepted:
2010-10-21
Published Online:
2011-02-03

Abstract

Background: The study is aimed at evaluating the performance of the predictive model ROMA (Risk of Ovarian Malignancy Algorithm), which utilizes the combination of human epididymis protein 4 (HE4) and CA125 values to assess the risk of epithelial ovarian cancer (EOC) in women with a pelvic mass.

Methods: One hundred and four women diagnosed with a pelvic mass (55 EOC and 49 benign cases) and scheduled to have surgery were enrolled, along with 49 healthy females. Preoperative serum concentrations of HE4 and CA125 were measured. Separate logistic regression algorithms ROMA for pre-menopausal and post-menopausal women were used to categorize patients into low- and high-risk groups for EOC. The area under the curve (AUC), sensitivity and specificity were calculated for HE4, CA125 and ROMA for the diagnosis of ovarian cancer using receiver operating characteristic (ROC) analysis.

Results: The median CA125 and HE4 serum concentrations were significantly higher among EOC patients than in healthy females (both p<0.05) and those with a benign mass (both p<0.05). The pre-menopausal group included 36 benign cases (29 of which were classified by ROMA as low-risk with a specificity of 80.6%; 95% CI: 64.0%–91.8%), and 15 EOC (eight of which were classified by ROMA as high-risk, with a sensitivity of 53.3%; 95% CI: 26.6%–78.7%). The post-menopausal group enclosed 13 benign cases (11 of which were classified by ROMA as low-risk with a specificity of 84.6%; 95% CI: 54.6%–98.0%), and 40 EOC (33 of which were classified by ROMA as high-risk with a sensitivity of 82.5%; 95% CI: 67.2%–92.7%). In the pre-menopausal group, the AUC was 0.64 (p=0.12, 95% CI: 0.44–0.83) for CA125, 0.77 (p=0.003, 95% CI: 0.62–0.92) for HE4 and 0.77 (p=0.002, 95% CI: 0.63–0.92) for ROMA. In the post-menopausal group, the AUC was 0.84 (p=0.0003, 95% CI: 0.73–0.94) for CA125, 0.94 (p<0.0001, 95% CI: 0.88–0.99) for HE4 and 0.92 (p<0.0001, 95% CI: 0.85–0.99) for ROMA.

Conclusions: The ROMA is a simple scoring system which shows excellent diagnostic performance for the detection of EOC in post-menopausal women, but not in pre-menopausal women. Moreover, the dual marker combination of HE4 and CA125 (ROMA) does not show better performance than HE4 alone.

Keywords: biomarkers; CA125; epithelial ovarian cancer; human epididymis protein 4; pelvic mass

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
L.-T. Jia, Y.-C. Zhang, J. Li, Y. Tian, and J.-F. Li
Clinical and Translational Oncology, 2015
[2]
Anthony Richards, Unine Herbst, Jane Manalang, Selvan Pather, Samir Saidi, Trevor Tejada-Berges, Kris Tan, Paul Williams, and Jonathan Carter
Australian and New Zealand Journal of Obstetrics and Gynaecology, 2015, Page n/a
[3]
Mona A. Karlsen, Estrid V.S. Høgdall, Ib J. Christensen, Christer Borgfeldt, Grigorios Kalapotharakos, Lenka Zdrazilova-Dubska, Josef Chovanec, Christianne A.R. Lok, Anna Stiekema, Irene Mutz-Dehbalaie, Adam N. Rosenthal, Elizabeth K. Moore, Beth A. Schodin, Walfrido W. Sumpaico, Karin Sundfeldt, Björg Kristjansdottir, Ignacio Zapardiel, and Claus K. Høgdall
Gynecologic Oncology, 2015
[4]
Jian-Xiang Shi, Jie-Jie Qin, Hua Ye, Peng Wang, Kai-Juan Wang, and Jian-Ying Zhang
Expert Review of Molecular Diagnostics, 2015, Page 1
[5]
Teresa Granato, Maria Grazia Porpora, Flavia Longo, Antonio Angeloni, Lucia Manganaro, and Emanuela Anastasi
Clinica Chimica Acta, 2015, Volume 446, Page 147
[6]
Mohamed A. Elzek and Karin D. Rodland
Cancer and Metastasis Reviews, 2015, Volume 34, Number 1, Page 83
[7]
Anita Monika Chudecka-Głaz
Clinica Chimica Acta, 2015, Volume 440, Page 143
[8]
Richard G. Moore, Douglas M. Hawkins, M. Craig Miller, Lisa M. Landrum, Walter Gajewski, John J. Ball, W. Jeffery Allard, and Steven J. Skates
Gynecologic Oncology, 2014, Volume 135, Number 3, Page 547
[9]
Sohiya Yotsukura and Hiroshi Mamitsuka
Critical Reviews in Oncology/Hematology, 2015, Volume 93, Number 2, Page 103
[10]
János Kappelmayer, Péter Antal-Szalmás, and Béla Nagy
Clinica Chimica Acta, 2015, Volume 438, Page 35
[11]
Farah Farzaneh, Zahra Honarvar, Mansoore Yaraghi, Mehdi Yaseri, Maliheh Arab, Maryamsadat Hosseini, and Tahereh Ashrafgangoi
Iranian Red Crescent Medical Journal, 2014, Volume 16, Number 6
[12]
Shi-Wen Jiang, Haibin Chen, Sean Dowdy, Alex Fu, John Attewell, Eleftheria Kalogera, Ronny Drapkin, Karl Podratz, Russell Broaddus, and Jinping Li
International Journal of Molecular Sciences, 2013, Volume 14, Number 11, Page 22655
[13]
Jiwen Wang, Jia Gao, Hongwen Yao, Zongyong Wu, Minjie Wang, and Jun Qi
Tumor Biology, 2014, Volume 35, Number 6, Page 6127
[14]
Richard G. Moore, Emily K. Hill, Timothy Horan, Naohiro Yano, KyuKwang Kim, Shannon MacLaughlan, Geralyn Lambert-Messerlian, YiTang Don Tseng, James F. Padbury, M. Craig Miller, Thilo S. Lange, and Rakesh K. Singh
Scientific Reports, 2014, Volume 4
[15]
J. Kaijser, T. Van Gorp, M.-E. Smet, C. Van Holsbeke, A. Sayasneh, E. Epstein, T. Bourne, I. Vergote, B. Van Calster, and D. Timmerman
Ultrasound in Obstetrics & Gynecology, 2014, Volume 43, Number 1, Page 89
[16]
J. Kaijser, A. Sayasneh, K. Van Hoorde, S. Ghaem-Maghami, T. Bourne, D. Timmerman, and B. Van Calster
Human Reproduction Update, 2014, Volume 20, Number 3, Page 449
[17]
N. Lahlou and J.-L. Brun
Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2013, Volume 42, Number 8, Page 752
[18]
Jingjing Yang, Mu Sa, Meng Huang, Jiajin Yang, Zhongyuan Xiang, Bo Liu, and Aiguo Tang
Clinical Biochemistry, 2013, Volume 46, Number 16-17, Page 1705
[19]
Karina Biskup, Elena I. Braicu, Jalid Sehouli, Christina Fotopoulou, Rudolf Tauber, Markus Berger, and Véronique Blanchard
Journal of Proteome Research, 2013, Volume 12, Number 9, Page 4056
[20]
Shin Hye Chung, Soo Yoon Lee, Woong Ju, and Seung Cheol Kim
Obstetrics & Gynecology Science, 2013, Volume 56, Number 4, Page 234
[21]
Brian M. Nolen and Anna E. Lokshin
Molecular Diagnosis & Therapy, 2013, Volume 17, Number 3, Page 139
[22]
Gina Brown
Journal of the American Academy of Physician Assistants, 2012, Volume 25, Number 8, Page 46
[23]
Jeroen Kaijser, Toon Van Gorp, Kirsten Van Hoorde, Caroline Van Holsbeke, Ahmad Sayasneh, Ignace Vergote, Tom Bourne, Dirk Timmerman, and Ben Van Calster
Gynecologic Oncology, 2013, Volume 129, Number 2, Page 377
[24]
J. Kaijser, T. Bourne, L. Valentin, A. Sayasneh, C. Van Holsbeke, I. Vergote, A. C. Testa, D. Franchi, B. Van Calster, and D. Timmerman
Ultrasound in Obstetrics & Gynecology, 2013, Volume 41, Number 1, Page 9
[25]
Robert E. Bristow, Alan Smith, Zhen Zhang, Daniel W. Chan, Gillian Crutcher, Eric T. Fung, and Donald G. Munroe
Gynecologic Oncology, 2013, Volume 128, Number 2, Page 252
[26]
Mona Aarenstrup Karlsen, Noreen Sandhu, Claus Høgdall, Ib Jarle Christensen, Lotte Nedergaard, Lene Lundvall, Svend A. Engelholm, Anette T. Pedersen, Dorthe Hartwell, Magnus Lydolph, Inga Alice Laursen, and Estrid V.S. Høgdall
Gynecologic Oncology, 2012, Volume 127, Number 2, Page 379
[27]
Jason E. Dodge, Allan L. Covens, Christina Lacchetti, Laurie M. Elit, Tien Le, Michaela Devries-Aboud, and Michael Fung-Kee-Fung
Gynecologic Oncology, 2012, Volume 126, Number 1, Page 157
[28]
Brian M Nolen and Anna E Lokshin
Expert Opinion on Medical Diagnostics, 2012, Volume 6, Number 2, Page 131
[30]
Richard G. Moore, Michael Craig Miller, Margaret M. Steinhoff, Steven J. Skates, Karen H. Lu, Geralyn Lambert-Messerlian, and Robert C. Bast
American Journal of Obstetrics and Gynecology, 2012, Volume 206, Number 4, Page 351.e1
[31]
Sasa Kadija, Aleksandar Stefanovic, Katarina Jeremic, Milos M. Radojevic, Ljubinka Nikolic, Ivanka Markovic, and Jasmina Atanackovic
International Journal of Gynecological Cancer, 2012, Volume 22, Number 2, Page 238
[32]
Nils Bolstad, Miriam Øijordsbakken, Kjell Nustad, and Johan Bjerner
Tumor Biology, 2012, Volume 33, Number 1, Page 141
[33]
Bohuslav Melichar and Mario Plebani
Clinical Chemistry and Laboratory Medicine, 2012, Volume 50, Number 3
[34]
Rafael Molina, Jose M. Escudero, Jose M. Augé, Xavier Filella, Laura Foj, Aureli Torné, Jose Lejarcegui, and Jaume Pahisa
Tumor Biology, 2011, Volume 32, Number 6, Page 1087
[35]
Bohuslav Melichar and Mario Plebani
Clinical Chemistry and Laboratory Medicine, 2012, Volume 50, Number 1, Page 1
[36]
Miriam Lenhard, Petra Stieber, Linda Hertlein, Angela Kirschenhofer, Sophie Fürst, Doris Mayr, Dorothea Nagel, Karin Hofmann, Katja Krocker, and Alexander Burges
Clinical Chemistry and Laboratory Medicine, 2011, Volume 49, Number 12
[37]
Giuseppina Ruggeri, Elisabetta Bandiera, Laura Zanotti, Silvana Belloli, Antonella Ravaggi, Chiara Romani, Eliana Bignotti, Renata A. Tassi, Germana Tognon, Claudio Galli, Luigi Caimi, and Sergio Pecorelli
Clinica Chimica Acta, 2011, Volume 412, Number 15-16, Page 1447
[38]
Richard G. Moore, M. Craig Miller, Paul Disilvestro, Lisa M. Landrum, Walter Gajewski, John J. Ball, and Steven J. Skates
Obstetrics & Gynecology, 2011, Volume 118, Number 2, Part 1, Page 280
[39]
Mario Plebani and Bohuslav Melichar
Clinical Chemistry and Laboratory Medicine, 2011, Volume 49, Number 3

Comments (0)

Please log in or register to comment.